Prevalence and incidence measures for schizophrenia among commercial health insurance and medicaid enrollees.
Prevalence and incidence measures for schizophrenia among commercial health insurance and medicaid enrollees. Schizophrenia (Heidelb). 2024 Aug 22; 10(1):68.
PMID: 39174558
Air quality and mental health: evidence, challenges and future directions.
Air quality and mental health: evidence, challenges and future directions. BJPsych Open. 2023 Jul 05; 9(4):e120.
PMID: 37403494
Author Correction: The high-dimensional space of human diseases built from diagnosis records and mapped to genetic loci.
Author Correction: The high-dimensional space of human diseases built from diagnosis records and mapped to genetic loci. Nat Comput Sci. 2023 Jul; 3(7):658.
PMID: 38214655
The high-dimensional space of human diseases built from diagnosis records and mapped to genetic loci.
The high-dimensional space of human diseases built from diagnosis records and mapped to genetic loci. Nat Comput Sci. 2023 May; 3(5):403-417.
PMID: 38177845
Peri- and Post-natal Risk Factors Associated with Health of Newborns: A pregnant mother's infections and immune diseases, and her baby's delivery method predict immune health of the newborn.
Peri- and Post-natal Risk Factors Associated with Health of Newborns: A pregnant mother's infections and immune diseases, and her baby's delivery method predict immune health of the newborn. medRxiv. 2023 Jan 17.
PMID: 36711636
OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics.
OrganoID: A versatile deep learning platform for tracking and analysis of single-organoid dynamics. PLoS Comput Biol. 2022 11; 18(11):e1010584.
PMID: 36350878
Discerning asthma endotypes through comorbidity mapping.
Discerning asthma endotypes through comorbidity mapping. Nat Commun. 2022 11 07; 13(1):6712.
PMID: 36344522
Gene-environment interactions explain a substantial portion of variability of common neuropsychiatric disorders.
Gene-environment interactions explain a substantial portion of variability of common neuropsychiatric disorders. Cell Rep Med. 2022 09 20; 3(9):100736.
PMID: 36070757
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview.
Building Programs to Eradicate Toxoplasmosis Part I: Introduction and Overview. Curr Pediatr Rep. 2022; 10(3):57-92.
PMID: 36034212
Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances "Take a Village".
Building Programs to Eradicate Toxoplasmosis Part IV: Understanding and Development of Public Health Strategies and Advances "Take a Village". Curr Pediatr Rep. 2022; 10(3):125-154.
PMID: 35991908